INDSWFTLAB

Ind-Swift Laboratories Share Price

 

 

Start SIP in INDSWFTLAB

Start SIP
Ind-Swift Laboratories live price: ₹138.85. It opened at ₹136 vs previous close ₹138; intraday high/low: ₹139/₹133. The 50 & 200 DMA stand at ₹131.18/₹112.81.

Ind-Swift Laboratories Performance

  • Today's Low
  • ₹133
  • Today's High
  • ₹139
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹152
  • Open Price₹136
  • Previous Close₹138
  • Volume144,731
  • 50 DMA₹131.18
  • 100 DMA₹121.17
  • 200 DMA₹112.81

Investment Returns

  • Over 1 Month + 1.18%
  • Over 3 Month + 51.67%
  • Over 6 Month + 42.6%
  • Over 1 Year + 55.26%

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Invest Now

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 4.9
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 1,206
  • P/B Ratio
  • 0.9
  • Average True Range
  • 8.76
  • EPS
  • 5.45
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.27
  • RSI
  • 51.54
  • MFI
  • 27.41

Ind-Swift Laboratories Financials

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹138.85
+ 0.68 (0.49%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹138.33
  • 50 Day
  • ₹131.18
  • 100 Day
  • ₹121.17
  • 200 Day
  • ₹112.81

Resistance and Support

137.19 Pivot Speed
  • R3 147.37
  • R2 143.42
  • R1 141.14
  • S1 134.91
  • S2 130.96
  • S3 128.68

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 594.47 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 46% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 27% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 28 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-31 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-08-11 Audited Results
2025-05-30 Audited Results

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

43.06%
0%
13.8%
0%
32.97%
10.17%

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹138 As on 04 April, 2026 | 04:57

The Market Cap of Ind-Swift Laboratories is ₹1205.7 Cr As on 04 April, 2026 | 04:57

The P/E ratio of Ind-Swift Laboratories is 4.9 As on 04 April, 2026 | 04:57

The PB ratio of Ind-Swift Laboratories is 0.9 As on 04 April, 2026 | 04:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23